Publications 2019


2019

Mass Cytometry Discovers Two Discrete Subsets of CD39-Treg Which Discriminate MGUS From Multiple Myeloma.

Marsh-Wakefield F, Kruzins A, McGuire HM, Yang S, Bryant C, Fazekas de St Groth B, Nassif N, Byrne SN, Gibson J, Brown C, Larsen S, McCulloch D, Boyle R, Clark G, Joshua D, Ho PJ,Vuckovic S.

Front Immunol. 2019 Aug 2;10:1596. doi: 10.3389/fimmu.2019.01596.


2019

Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model

Guillerey C, Nakamura K, Pichler AC, Barkauskas D, Krumeich S, Stannard K, Miles K, Harjunpää H, Yu Y, Casey M, Doban AI, Lazar M, Hartel G, Smith D, Vuckovic S, Teng MW, Bergsagel PL, Chesi M, Hill GR, Martinet L, Smyth MJ.

JCI Insight. 2019 Jun 13;5. pii: 125932. doi: 10.1172/jci.insight.125932


2019

Curative strategies in acute promyelocytic leukemia.

Iland HJ.

Sem Hematol 2019;56(2):131-138.


2019

Management of Acute Promyelocytic Leukemia: Updated Recommendations from an Expert Panel of the European LeukemiaNet.

Sanz MA, Fenaux P, Tallman MS, Estey EH, Löwenberg B, Naoe T, Lengfelder E, Doehner H, Burnett AK, Chen SJ, Mathews V, Iland HJ, Rego E, Kantajian HM, Ades L, Avvisati G, Montesinos P, Platzbecker U, Ravandi F, Russell NH, and Lo Coco F.

Blood 2019;133(15):1630-1643


2019

Targeting the niche: depleting haemopoietic stem cells with targeted therapy

Abadir E, Bryant C, Larsen S, Clark GJ.

Bone marrow transplantation. 2019 Jan 21:1.


2019

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.

Abadir E, Gasiorowski RE, Lai K, Kupresanin F, Romano A, Silveira PA, Lo TH, Fromm PD, Kennerson ML, Iland HJ, Ho PJ.

Molecular oncology. 2019 Jul 23.


2019

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.

Lo TH, Abadir E, Gasiorowski RE, Kabani K, Ramesh M, Orellana D, Fromm PD, Kupresanin F, Newman E, Cunningham I, Hart DN. PloS one.

2019 May 10;14(5):e0216368


2019

CD83: activation marker for antigen presenting cells and its therapeutic potential

Li Z, Ju X, Silveira PA, Abadir E, Hsu WH, Hart DN, Clark G.

Frontiers in immunology. 2019;10:1312.